- Home
- GRNT vs EMBC Comparison
GRNT vs EMBC Comparison
Compare GRNT & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRNT
- EMBC
- Stock Information
- Founded
- GRNT 2013
- EMBC 1924
- Country
- GRNT United States
- EMBC United States
- Employees
- GRNT N/A
- EMBC N/A
- Industry
- GRNT Blank Checks
- EMBC Medical/Dental Instruments
- Sector
- GRNT Finance
- EMBC Health Care
- Exchange
- GRNT Nasdaq
- EMBC Nasdaq
- Market Cap
- GRNT 793.2M
- EMBC 788.4M
- IPO Year
- GRNT N/A
- EMBC N/A
- Fundamental
- Price
- GRNT $5.41
- EMBC $15.22
- Analyst Decision
- GRNT Buy
- EMBC Buy
- Analyst Count
- GRNT 2
- EMBC 2
- Target Price
- GRNT $7.50
- EMBC $18.50
- AVG Volume (30 Days)
- GRNT 565.0K
- EMBC 507.0K
- Earning Date
- GRNT 11-06-2025
- EMBC 08-08-2025
- Dividend Yield
- GRNT 8.16%
- EMBC 3.90%
- EPS Growth
- GRNT N/A
- EMBC 18.26
- EPS
- GRNT 0.25
- EMBC 1.42
- Revenue
- GRNT $409,332,000.00
- EMBC $1,102,500,000.00
- Revenue This Year
- GRNT $34.49
- EMBC N/A
- Revenue Next Year
- GRNT $13.97
- EMBC N/A
- P/E Ratio
- GRNT $21.91
- EMBC $10.82
- Revenue Growth
- GRNT 10.32
- EMBC N/A
- 52 Week Low
- GRNT $4.52
- EMBC $9.20
- 52 Week High
- GRNT $7.00
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- GRNT 50.39
- EMBC 68.43
- Support Level
- GRNT $5.19
- EMBC $14.51
- Resistance Level
- GRNT $5.67
- EMBC $15.44
- Average True Range (ATR)
- GRNT 0.17
- EMBC 0.51
- MACD
- GRNT -0.01
- EMBC -0.04
- Stochastic Oscillator
- GRNT 37.50
- EMBC 88.69
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.